Azenta Recovers Full $63 Million From B Medical Systems Sale
Burlington, Mass. – September 08, 2026 -- Azenta, Inc. (Nasdaq: AZTA) has received full repayment, ahead of maturity, of a $35 million secured vendor loan tied to its divestiture of B Medical Systems S.à r.l., closing out the transaction with the entire $63 million purchase price now collected in cash.
Azenta collects $35 million vendor loan before maturity
Azenta Germany GmbH, a wholly owned subsidiary, had extended the secured term loan to buyer Thelema S.à r.l. as part of the sale that closed July 1, 2026. The loan was secured by a pledge over B Medical Systems' equity interests. Thelema repaid the principal along with all accrued interest, and Azenta released the share pledge that secured the debt.
Total cash proceeds reach $63 million
With the vendor loan settled, Azenta has now received the full $63 million purchase price for B Medical Systems in cash, eliminating the credit exposure the company carried since the deal closed.